NCT02594436View on ClinicalTrials.gov

The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical Practice

CompletedOBSERVATIONAL

Enrollment

440

Participants

Timeline

Start Date

December 1, 2015

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions

Actinic Keratosis

Interventions

DRUG

Ingenol mebutate

Non-Interventional study enrolling patients already planned to be treated with ingenol mebutate according to approved labelling

Trial Locations (1)

12134

Office Based Physician, Athens

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LEO Pharma

INDUSTRY